Literature DB >> 11991436

Vitamin D and muscle function.

M Pfeifer1, B Begerow, H W Minne.   

Abstract

The aim of this review is to summarize current knowledge on the relation between vitamin D and muscle function. Molecular mechanisms of vitamin D action on muscle tissue have been known for many years and include genomic and non-genomic effects. Genomic effects are initiated by binding of 1,25-dihydroxyvitamin D3 (1,25(OH)2D) to its nuclear receptor, which results in changes in gene transcription of messenger RNA and subsequent protein synthesis. Non-genomic effects of vitamin D are rapid and mediated through a membrane-bound vitamin D receptor (VDR). Genetic variations in the VDR and the importance of VDR polymorphisms in the development of osteoporosis are still a matter of controversy and debate. Most recently, VDR polymorphisms have been described to affect muscle function. The skin has an enormous capacity for vitamin D production and supplies the body with 80-100% of its requirements of vitamin D. Age, latitude, time of day, season of the year and pigmentation can dramatically affect the production of vitamin D in the skin. Hypovitaminosis D is a common feature in elderly people living in northern latitudes and skin coverage has been established as an important factor leading to vitamin D deficiency. A serum 25-hydroxyvitamin D level below 50 nmol/l has been associated with increased body sway and a level below 30 nmol/l with decreased muscle strength. Changes in gait, difficulties in rising from a chair, inability to ascend stairs and diffuse muscle pain are the main clinical symptoms in osteomalacic myopathy. Calcium and vitamin D supplements together might improve neuromuscular function in elderly persons who are deficient in calcium and vitamin D. Thus 800 IU of cholecalciferol in combination with mg of elemental calcium reduces hip fractures and other non-vertebral fractures and should generally be recommended in individuals who are deficient in calcium and vitamin D. Given the strong interdependency of vitamin D deficiency, low serum calcium and high levels of parathyroid hormone, however, it is difficult to identify exact mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991436     DOI: 10.1007/s001980200012

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  127 in total

1.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

Review 2.  The biology and pathology of vitamin D control in bone.

Authors:  Taison D Bell; Marie B Demay; Sherri-Ann M Burnett-Bowie
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway.

Authors:  Kirsten Valebjørg Knutsen; Mette Brekke; Svein Gjelstad; Per Lagerløv
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

4.  Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations.

Authors:  S W Kim; N Hong; Y Rhee; Y-C Choi; H Y Shin; S M Kim
Journal:  Osteoporos Int       Date:  2018-04-05       Impact factor: 4.507

5.  Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women.

Authors:  P Gerdhem; K A M Ringsberg; K J Obrant; K Akesson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

6.  Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents.

Authors:  V Chel; H A H Wijnhoven; J H Smit; M Ooms; P Lips
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

7.  Vitamin D and gallstone disease-A population-based study.

Authors:  Daniel Mønsted Shabanzadeh; Torben Jørgensen; Allan Linneberg; Lars Tue Sørensen; Tea Skaaby
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

8.  Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials.

Authors:  Lars Rejnmark
Journal:  Ther Adv Chronic Dis       Date:  2011-01       Impact factor: 5.091

9.  Vitamin D status: effects on quality of life in osteoporosis among Turkish women.

Authors:  Sibel Basaran; Rengin Guzel; Ilke Coskun-Benlidayi; Fusun Guler-Uysal
Journal:  Qual Life Res       Date:  2007-09-09       Impact factor: 4.147

Review 10.  Treatment Options for Statin-Associated Muscle Symptoms.

Authors:  Ulrich Laufs; Hubert Scharnagl; Martin Halle; Eberhard Windler; Matthias Endres; Winfried März
Journal:  Dtsch Arztebl Int       Date:  2015-10-30       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.